Organophosphorous
compounds are still widely used as potential
scale inhibitors in the upstream oil and gas industry, particularly
in squeeze treatments as they have good adsorption properties on rock
and are easily detectable. However, most phosphonate-based scale inhibitors
have some drawbacks, such as poor biodegradability and various incompatibilities
with the production system. The low toxicity of bisphosphonates motivated
us to test a series of aliphatic and aromatic hydroxybisphosphonates
as new oilfield scale inhibitors for calcium carbonate (calcite) and
barium sulfate (barite) scales. Thus, the well-known bone-targeting
drugs 3-amino-1-hydroxypropane-1,1-bisphosphonic acid (pamidronic
acid, SI-1), 4-amino-1-hydroxybutane-1,1-bisphosphonic
acid (alendronic acid, SI-2), 5-amino-1-hydroxypentane-1,1-bisphosphonic
acid (SI-3), and hydroxyphenylmethylene-1,1-bisphosphonic
acid (fenidronic acid, SI-6) are studied along with novel,
specially designed bisphosphonates (1,4-dihydroxybutane-1,1,4,4-tetrayl)tetrakisphosphonic
acid (SI-4), (1,6-dihydroxyhexane-1,1,6,6-tetrayl)tetrakisphosphonic
acid (SI-5), and ((4- aminophenyl)(hydroxy)methylene)bisphosphonic
acid (SI-7) in a dynamic tube-blocking scale rig at 100
°C and 80 bar according to typical North Sea conditions. The
scale inhibition performance of the new SIs was compared to that of
the commercial 1-hydroxyethylidene bisphosphonic acid (HEDP) and aminotrismethylenephosphonic acid (ATMP). The
results indicate that all synthesized hydroxybisphosphonates provide
reasonable inhibition performance against calcite scaling and show
good thermal stability at 130 °C for 7 days under anaerobic conditions.